Showing results (471-480 of 610) with videos related to
Sort By:
Pageof 61
Blood|January 29, 2000
Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinaseS Vanwetswinkel, S Plaisance, Z Zhi-Yong, et al.Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|August 1, 1992
Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosisI K Jang, H K Gold, R C Leinbach, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activatorsG Leonardsson, X R Peng, K Liu, et al.DNA and Cell Biology|June 1, 1996
Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 geneH Ding, K Descheemaeker, P Marynen, et al.Thrombosis and Haemostasis|July 31, 1998
Cloning and characterization of a cDNA encoding murine coagulation factor XZ Liang, A Cooper, M E DeFord, et al.Thrombosis and Haemostasis|January 1, 1994
Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosisD Collen, H R Lu, J M Stassen, et al.The Journal of Biological Chemistry|September 5, 1991
Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimerY Laroche, M Demaeyer, J M Stassen, et al.The Journal of Biological Chemistry|September 8, 2001
Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxiaK Brusselmans, F Bono, P Maxwell, et al.The Journal of Biological Chemistry|June 20, 1997
Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activationA Dhoest, Z Zhao, B De Geest, et al.Circulation|January 1, 1990
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibitionI K Jang, H K Gold, A A Ziskind, et al.Pageof 61